Humacyte Stock Forecast

Sell candidate since Jun 12, 2026 Loss -34.48%

The Humacyte, Inc. stock price fell by -0.360% on the last day (Monday, 13th Jul 2026) from $0.694 to $0.691. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 4.40% from a day low at $0.680 to a day high of $0.710. The price has fallen in 6 of the last 10 days and is down by -2.46% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -6 million shares and in total, 8 million shares were bought and sold for approximately $5.21 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.628 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 3.03% during the next 3 months and, with a 90% probability hold a price between $0.647 and $1.55 at the end of this 3-month period.

HUMA Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Humacyte, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.724 and $1.00. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -53.61%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Humacyte, Inc. stock

Humacyte, Inc. finds support from accumulated volume at $0.684 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0299 between high and low, or 4.40%. For the last week, the stock has had daily average volatility of 7.64%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HUMA) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Humacyte, Inc. to open at $0.694, and during the day (based on 14 day Average True Range), to move between $0.641 and $0.741, which gives a possible trading interval of +/-$0.100 (+/-15.63%) up or down from last closing price. If Humacyte, Inc. takes out the full calculated possible swing range there will be an estimated 15.63% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.684 (1.10%) than the resistance at $0.700 (1.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Humacyte, Inc. stock A Buy?

The Humacyte, Inc. stock holds several negative signals and despite the positive trend, we believe Humacyte, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -5.411 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $0.694 ( 0.362%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk